ATE417825T1 - Neue gene tzap7/a, tzap7/b and tzap7 welche in die t zellen aktivierung involviert sind, und deren verwendungen - Google Patents

Neue gene tzap7/a, tzap7/b and tzap7 welche in die t zellen aktivierung involviert sind, und deren verwendungen

Info

Publication number
ATE417825T1
ATE417825T1 AT00984944T AT00984944T ATE417825T1 AT E417825 T1 ATE417825 T1 AT E417825T1 AT 00984944 T AT00984944 T AT 00984944T AT 00984944 T AT00984944 T AT 00984944T AT E417825 T1 ATE417825 T1 AT E417825T1
Authority
AT
Austria
Prior art keywords
tzap7
proteins
polynucleotides
vectors
antibodies
Prior art date
Application number
AT00984944T
Other languages
English (en)
Inventor
Nalan Utku
Edgar L Milford
Original Assignee
Nalan Utku
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nalan Utku, Brigham & Womens Hospital filed Critical Nalan Utku
Application granted granted Critical
Publication of ATE417825T1 publication Critical patent/ATE417825T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
AT00984944T 1999-11-01 2000-10-30 Neue gene tzap7/a, tzap7/b and tzap7 welche in die t zellen aktivierung involviert sind, und deren verwendungen ATE417825T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16267599P 1999-11-01 1999-11-01
US18501600P 2000-02-25 2000-02-25

Publications (1)

Publication Number Publication Date
ATE417825T1 true ATE417825T1 (de) 2009-01-15

Family

ID=26858965

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00984944T ATE417825T1 (de) 1999-11-01 2000-10-30 Neue gene tzap7/a, tzap7/b and tzap7 welche in die t zellen aktivierung involviert sind, und deren verwendungen

Country Status (8)

Country Link
US (2) US20030027261A1 (de)
EP (1) EP1230214B1 (de)
JP (1) JP2003518925A (de)
AT (1) ATE417825T1 (de)
AU (1) AU779839B2 (de)
CA (1) CA2389415A1 (de)
DE (1) DE60041148D1 (de)
WO (1) WO2001032614A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004033137A (ja) * 2002-07-05 2004-02-05 Tasuku Honjo 抗癌剤のスクリーニング方法
CN112251465A (zh) * 2020-10-22 2021-01-22 广州华腾生物医药科技有限公司 一种tzap基因或蛋白作为提高间充质干细胞增殖及分化能力的靶点中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1002132A4 (de) * 1997-08-05 2005-04-27 Human Genome Sciences Inc Humane sekretierte proteine
AU2212299A (en) * 1998-01-05 1999-07-26 Genentech Inc. Compositions and methods for the treatment of tumor
EP1196575A2 (de) * 1999-07-19 2002-04-17 Incyte Genomics, Inc. An gtp-bindende proteine assoziierte faktoren

Also Published As

Publication number Publication date
EP1230214A2 (de) 2002-08-14
US20030027261A1 (en) 2003-02-06
WO2001032614A3 (en) 2001-11-08
US20070212714A1 (en) 2007-09-13
DE60041148D1 (de) 2009-01-29
AU2153901A (en) 2001-05-14
WO2001032614A9 (en) 2002-09-06
WO2001032614A2 (en) 2001-05-10
EP1230214B1 (de) 2008-12-17
JP2003518925A (ja) 2003-06-17
AU779839B2 (en) 2005-02-17
CA2389415A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
ATE443161T1 (de) Mittel und verfahren für den nachweis von methylierter dna
EP2248892A3 (de) Fusionskonstruktionen und deren Verwendung zur Herstellung von Antikörpern mit erhöhter Fc-Rezeptor-Bindeaffinität und Effektorfunktion
PT1587532E (pt) Péptidos derivados de survivina e a sua utilização
AR038568A1 (es) Anticuerpos anti-a beta y su uso
EP2277888A3 (de) Fusionsprotein von Albumin und Erythropoietin
WO2004069876A3 (en) Trimeric polypeptide construct to induce an enduring t cell response
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
DE69431834D1 (de) Für den vorläufer des für die tumorabstossung verantwortlichen antigens mage-3 kodierendes, isoliertes nukleinsäuremolekül und seine verwendung
DK43890D0 (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
EE05293B1 (et) RG1 polpeptiidiga seonduv antikeha, seda h?lmav immunkonjugaat ja nende kasutamine
ATE417825T1 (de) Neue gene tzap7/a, tzap7/b and tzap7 welche in die t zellen aktivierung involviert sind, und deren verwendungen
GEP20043386B (en) β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same
ATE435277T1 (de) 18477, eine menschliche proteinkinase und deren verwendung
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2001064913A3 (en) Cell cycle proteins associated with rad9, compositions and methods of use
DE60120507D1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
WO2001021654A3 (en) Syk kinase-associated cell cycle proteins, compositions and methods of use
AU2001263888A1 (en) Uses of tgap7 for the modulation of leucocyte activation
WO2001036476A3 (en) Ing2, an iaps associated cell cycle protein, compositions and methods of use
WO2004011496A3 (en) Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
AU2001281943A1 (en) The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof
AU2002350406A1 (en) Identification of ses-3 (spr-5) in c. elegans and the uses of the same
WO1999042586A3 (en) Exo1 and exo2, exocytotic proteins
EP1666594A3 (de) Polypeptide, dafür kodierende Nukleinsäuren, und deren Verwendung zur Diagnose von Krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties